History of prostate cancer. Evaluate for possible MR ultrasound fusion biopsy. 5/13/2016 prostatic adenocarcinoma Gleason score 7 (3+4) (ISUP grade group 2), tumor volume is 40% of the submitted tissue. PSA 5.43 on 12/20/2016. PELVIS:PROSTATE:Prostate Size: 4.0 x 5.6 x 5.4 cmPeripheral Zone: Demonstrated again in the paramedial right mid gland is a 1.5 x 0.6 cm T2 weighted hypointense lesion with associated restricted diffusion (series 403 image 304), suspicious for prostatic adenocarcinoma. The lesion extends towards the base. It is not significantly changed from the prior. This lesion is associated with faint arterial enhancement. Additional punctate 3 mm focus in the lateral right peripheral zone of the mid gland is noted, unchanged.Punctate 3 mm focus in the lateral left peripheral zone of the base is noted, unchanged. Central Gland: Changes of BPH.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: The right peripheral zone paramedial lesion abuts the capsule without specific evidence of extracapsular extension.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1. Stable right mid-gland to base peripheral zone lesion with imaging characteristics suspicious for prostatic carcinoma. No specific evidence of extraprostatic extension or pelvic lymphadenopathy. 2. Additional punctate foci of abnormal signal in the right and left lateral peripheral zone are unchanged. 